Rui Zhao
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Tyrosine Phosphatases | 15 | 2025 | 172 | 4.450 |
Why?
| | Spliceosomes | 11 | 2021 | 48 | 2.810 |
Why?
| | RNA Splicing | 8 | 2024 | 269 | 2.690 |
Why?
| | RNA Precursors | 8 | 2024 | 154 | 2.650 |
Why?
| | Saccharomyces cerevisiae | 8 | 2024 | 557 | 2.160 |
Why?
| | Alcohol Oxidoreductases | 7 | 2021 | 62 | 1.980 |
Why?
| | DNA-Binding Proteins | 12 | 2025 | 1502 | 1.960 |
Why?
| | Protein Phosphatase 2 | 3 | 2025 | 41 | 1.930 |
Why?
| | Intracellular Signaling Peptides and Proteins | 9 | 2024 | 455 | 1.510 |
Why?
| | Saccharomyces cerevisiae Proteins | 7 | 2024 | 405 | 1.500 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 2 | 2024 | 13 | 1.450 |
Why?
| | Nuclear Proteins | 9 | 2024 | 712 | 1.330 |
Why?
| | Cryoelectron Microscopy | 5 | 2025 | 190 | 1.210 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2025 | 139 | 1.150 |
Why?
| | Peptides | 3 | 2025 | 985 | 1.140 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 4 | 2015 | 11 | 1.020 |
Why?
| | RNA | 4 | 2023 | 921 | 0.990 |
Why?
| | Introns | 4 | 2021 | 258 | 0.940 |
Why?
| | DEAD-box RNA Helicases | 2 | 2020 | 76 | 0.910 |
Why?
| | Thrombectomy | 1 | 2025 | 69 | 0.900 |
Why?
| | RNA Helicases | 3 | 2015 | 30 | 0.870 |
Why?
| | Rosaniline Dyes | 1 | 2024 | 13 | 0.870 |
Why?
| | Protein Binding | 17 | 2025 | 2224 | 0.800 |
Why?
| | High-Throughput Screening Assays | 3 | 2014 | 158 | 0.790 |
Why?
| | Crystallography, X-Ray | 8 | 2019 | 476 | 0.740 |
Why?
| | Thrombosis | 1 | 2025 | 371 | 0.720 |
Why?
| | Robotics | 1 | 2022 | 94 | 0.700 |
Why?
| | Models, Molecular | 10 | 2019 | 1570 | 0.700 |
Why?
| | RNA, Small Nuclear | 4 | 2015 | 37 | 0.690 |
Why?
| | RNA, Fungal | 3 | 2017 | 72 | 0.680 |
Why?
| | Transcriptional Activation | 4 | 2021 | 378 | 0.680 |
Why?
| | Enzyme Inhibitors | 4 | 2024 | 840 | 0.650 |
Why?
| | Homeodomain Proteins | 5 | 2020 | 506 | 0.650 |
Why?
| | Carrier Proteins | 3 | 2017 | 771 | 0.630 |
Why?
| | Cell-Penetrating Peptides | 1 | 2018 | 21 | 0.580 |
Why?
| | Exons | 1 | 2019 | 355 | 0.580 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 3 | 2013 | 11 | 0.560 |
Why?
| | Adenosine Triphosphatases | 3 | 2009 | 168 | 0.560 |
Why?
| | Mitochondria | 1 | 2024 | 948 | 0.560 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 434 | 0.550 |
Why?
| | Alternative Splicing | 2 | 2017 | 229 | 0.540 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 156 | 0.520 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 861 | 0.520 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 202 | 0.500 |
Why?
| | Neoplasms | 4 | 2024 | 2671 | 0.500 |
Why?
| | Branchio-Oto-Renal Syndrome | 2 | 2013 | 6 | 0.490 |
Why?
| | Naphthoquinones | 1 | 2014 | 19 | 0.460 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2017 | 327 | 0.460 |
Why?
| | Neoplasm Metastasis | 5 | 2025 | 658 | 0.460 |
Why?
| | Nucleic Acid Conformation | 2 | 2017 | 728 | 0.440 |
Why?
| | Adenosine Triphosphate | 5 | 2010 | 491 | 0.420 |
Why?
| | Amino Acid Sequence | 10 | 2018 | 2139 | 0.410 |
Why?
| | Molecular Sequence Data | 10 | 2014 | 2900 | 0.410 |
Why?
| | Protein Structure, Secondary | 4 | 2009 | 374 | 0.380 |
Why?
| | RNA Splice Sites | 2 | 2024 | 45 | 0.360 |
Why?
| | Transcription, Genetic | 2 | 2014 | 1457 | 0.340 |
Why?
| | Cell Line, Tumor | 8 | 2025 | 3412 | 0.340 |
Why?
| | DNA Helicases | 3 | 2007 | 145 | 0.340 |
Why?
| | Cell Movement | 2 | 2014 | 967 | 0.330 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2607 | 0.300 |
Why?
| | Animals | 21 | 2025 | 36940 | 0.300 |
Why?
| | Pharmaceutical Preparations | 1 | 2010 | 179 | 0.300 |
Why?
| | Protein Kinases | 1 | 2010 | 319 | 0.290 |
Why?
| | Humans | 33 | 2025 | 137585 | 0.290 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2008 | 25 | 0.290 |
Why?
| | Ribosomal Proteins | 1 | 2008 | 93 | 0.290 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2008 | 46 | 0.280 |
Why?
| | Macrolides | 1 | 2008 | 65 | 0.280 |
Why?
| | Antineoplastic Agents | 4 | 2024 | 2129 | 0.280 |
Why?
| | Structure-Activity Relationship | 3 | 2024 | 570 | 0.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1396 | 0.240 |
Why?
| | Cerebral Arteries | 1 | 2025 | 59 | 0.230 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 115 | 0.230 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2007 | 199 | 0.230 |
Why?
| | Fibrin | 1 | 2025 | 81 | 0.230 |
Why?
| | Hair Color | 1 | 2024 | 15 | 0.220 |
Why?
| | Saccharomycetales | 1 | 2024 | 27 | 0.220 |
Why?
| | Hyperpigmentation | 1 | 2024 | 26 | 0.220 |
Why?
| | Melanocytes | 1 | 2024 | 65 | 0.210 |
Why?
| | HEK293 Cells | 2 | 2024 | 730 | 0.210 |
Why?
| | Drug Design | 1 | 2024 | 167 | 0.210 |
Why?
| | Ribonucleoproteins, Small Nuclear | 2 | 2013 | 24 | 0.200 |
Why?
| | Tyrosine | 1 | 2024 | 222 | 0.200 |
Why?
| | Small Molecule Libraries | 2 | 2014 | 94 | 0.200 |
Why?
| | Swine | 1 | 2025 | 775 | 0.200 |
Why?
| | NF-kappa B | 2 | 2025 | 691 | 0.200 |
Why?
| | Protein Domains | 1 | 2024 | 289 | 0.190 |
Why?
| | Motion | 1 | 2022 | 99 | 0.190 |
Why?
| | Bacterial Proteins | 1 | 2008 | 879 | 0.180 |
Why?
| | Phosphorylation | 2 | 2024 | 1759 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 449 | 0.180 |
Why?
| | Locomotion | 1 | 2022 | 106 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2024 | 2057 | 0.170 |
Why?
| | Eukaryotic Initiation Factor-4E | 2 | 2011 | 27 | 0.170 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 496 | 0.170 |
Why?
| | Protein Structure, Quaternary | 2 | 2019 | 128 | 0.170 |
Why?
| | Psoriasis | 1 | 2021 | 102 | 0.170 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 385 | 0.170 |
Why?
| | Co-Repressor Proteins | 1 | 2020 | 18 | 0.160 |
Why?
| | Mutation | 3 | 2009 | 3958 | 0.160 |
Why?
| | Allosteric Regulation | 2 | 2024 | 97 | 0.160 |
Why?
| | Binding Sites | 7 | 2013 | 1303 | 0.160 |
Why?
| | Erythrocytes | 1 | 2025 | 700 | 0.160 |
Why?
| | Mice | 9 | 2025 | 17787 | 0.150 |
Why?
| | Pulmonary Artery | 1 | 2025 | 1086 | 0.150 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 24 | 0.150 |
Why?
| | Substrate Specificity | 3 | 2014 | 372 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 48 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1670 | 0.140 |
Why?
| | MCF-7 Cells | 2 | 2020 | 124 | 0.140 |
Why?
| | Microglia | 1 | 2020 | 251 | 0.140 |
Why?
| | Molecular Targeted Therapy | 2 | 2017 | 411 | 0.130 |
Why?
| | Computer Security | 1 | 2017 | 23 | 0.130 |
Why?
| | Cytoplasm | 2 | 2008 | 274 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2019 | 363 | 0.130 |
Why?
| | RNA-Binding Proteins | 2 | 2013 | 422 | 0.130 |
Why?
| | BRCA1 Protein | 2 | 2020 | 76 | 0.130 |
Why?
| | Breast Neoplasms | 4 | 2020 | 2253 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 217 | 0.120 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 163 | 0.120 |
Why?
| | DNA Repair | 1 | 2017 | 231 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 665 | 0.120 |
Why?
| | Protein Conformation | 5 | 2014 | 934 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 843 | 0.120 |
Why?
| | Genes, Fungal | 1 | 2015 | 52 | 0.120 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2014 | 340 | 0.120 |
Why?
| | Sequence Alignment | 3 | 2014 | 343 | 0.120 |
Why?
| | Interleukin-1 | 1 | 2019 | 965 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2020 | 209 | 0.110 |
Why?
| | DNA Damage | 1 | 2017 | 420 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2020 | 360 | 0.110 |
Why?
| | Protein Unfolding | 1 | 2014 | 31 | 0.110 |
Why?
| | RNA Nucleotidyltransferases | 1 | 2014 | 21 | 0.110 |
Why?
| | Urea | 1 | 2014 | 81 | 0.110 |
Why?
| | Signal Transduction | 5 | 2025 | 5079 | 0.110 |
Why?
| | Antigens, Polyomavirus Transforming | 2 | 2004 | 18 | 0.110 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 86 | 0.110 |
Why?
| | Calorimetry | 1 | 2014 | 70 | 0.110 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 114 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 427 | 0.110 |
Why?
| | Drug Discovery | 1 | 2014 | 142 | 0.110 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.110 |
Why?
| | Stomatitis | 1 | 2013 | 14 | 0.100 |
Why?
| | Smad7 Protein | 1 | 2013 | 19 | 0.100 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 828 | 0.100 |
Why?
| | Phenylhydrazines | 1 | 2012 | 5 | 0.100 |
Why?
| | Cell Line | 2 | 2019 | 2847 | 0.100 |
Why?
| | Miniaturization | 1 | 2012 | 22 | 0.100 |
Why?
| | Protein Phosphatase 2C | 1 | 2012 | 15 | 0.100 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.100 |
Why?
| | Enzyme Assays | 1 | 2012 | 24 | 0.100 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 47 | 0.100 |
Why?
| | beta Catenin | 1 | 2014 | 253 | 0.100 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2012 | 67 | 0.100 |
Why?
| | RNA, Messenger | 2 | 2013 | 2833 | 0.100 |
Why?
| | Internet | 1 | 2017 | 655 | 0.090 |
Why?
| | Catalysis | 2 | 2014 | 307 | 0.090 |
Why?
| | DNA Replication | 2 | 2004 | 238 | 0.090 |
Why?
| | Circular Dichroism | 2 | 2014 | 149 | 0.090 |
Why?
| | Transforming Growth Factor beta | 2 | 2013 | 480 | 0.090 |
Why?
| | RNA Cap Analogs | 1 | 2011 | 6 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 168 | 0.090 |
Why?
| | Helminth Proteins | 1 | 2011 | 24 | 0.090 |
Why?
| | Amino Acid Motifs | 3 | 2007 | 225 | 0.090 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2011 | 44 | 0.090 |
Why?
| | Nanoparticles | 1 | 2017 | 481 | 0.090 |
Why?
| | Mice, Nude | 1 | 2013 | 698 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2013 | 341 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2015 | 706 | 0.090 |
Why?
| | Histidine Kinase | 1 | 2010 | 34 | 0.090 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2010 | 62 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 353 | 0.080 |
Why?
| | Hydrolysis | 2 | 2007 | 177 | 0.080 |
Why?
| | Schistosoma mansoni | 1 | 2009 | 37 | 0.080 |
Why?
| | Cadherins | 1 | 2011 | 206 | 0.080 |
Why?
| | RNA Caps | 1 | 2009 | 35 | 0.080 |
Why?
| | Female | 9 | 2025 | 73304 | 0.080 |
Why?
| | Base Sequence | 1 | 2013 | 2181 | 0.080 |
Why?
| | Protozoan Proteins | 1 | 2009 | 82 | 0.080 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 183 | 0.080 |
Why?
| | Ribonuclease H | 1 | 2008 | 12 | 0.080 |
Why?
| | Down-Regulation | 1 | 2011 | 657 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.070 |
Why?
| | Adenylyl Imidodiphosphate | 1 | 2008 | 5 | 0.070 |
Why?
| | Novobiocin | 1 | 2008 | 5 | 0.070 |
Why?
| | DNA Gyrase | 1 | 2008 | 12 | 0.070 |
Why?
| | Lactams, Macrocyclic | 1 | 2008 | 49 | 0.070 |
Why?
| | Benzoquinones | 1 | 2008 | 48 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2008 | 150 | 0.070 |
Why?
| | Cell Nucleus | 2 | 2009 | 620 | 0.070 |
Why?
| | Retinitis Pigmentosa | 1 | 2007 | 20 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2008 | 207 | 0.070 |
Why?
| | DNA | 4 | 2010 | 1459 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2011 | 399 | 0.070 |
Why?
| | Protein Folding | 1 | 2008 | 280 | 0.070 |
Why?
| | Crystallization | 1 | 2007 | 143 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3284 | 0.060 |
Why?
| | Keratinocytes | 2 | 2021 | 249 | 0.060 |
Why?
| | Serine | 2 | 2023 | 141 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2024 | 2475 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 889 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2024 | 194 | 0.050 |
Why?
| | Male | 4 | 2025 | 67762 | 0.050 |
Why?
| | Protein Stability | 2 | 2018 | 176 | 0.050 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.050 |
Why?
| | Simian virus 40 | 1 | 2003 | 24 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 23 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 22 | 0.050 |
Why?
| | Receptors, Odorant | 1 | 2003 | 32 | 0.050 |
Why?
| | Molecular Structure | 1 | 2024 | 489 | 0.050 |
Why?
| | Pedigree | 1 | 2024 | 514 | 0.050 |
Why?
| | Escherichia coli | 1 | 2007 | 815 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 40 | 0.050 |
Why?
| | Cell Lineage | 1 | 2024 | 350 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 327 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 271 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2003 | 233 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1738 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2019 | 611 | 0.040 |
Why?
| | Hydrogen Bonding | 2 | 2014 | 163 | 0.040 |
Why?
| | Astrocytes | 1 | 2020 | 210 | 0.040 |
Why?
| | Protein Multimerization | 1 | 2019 | 192 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 872 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5757 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2167 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3196 | 0.030 |
Why?
| | Promoter Regions, Genetic | 2 | 2011 | 1250 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2024 | 1238 | 0.030 |
Why?
| | Protein Denaturation | 1 | 2014 | 74 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 739 | 0.030 |
Why?
| | rac GTP-Binding Proteins | 1 | 2013 | 32 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2013 | 56 | 0.020 |
Why?
| | Neuropeptides | 1 | 2013 | 73 | 0.020 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.020 |
Why?
| | Ascaris suum | 1 | 2011 | 5 | 0.020 |
Why?
| | Macrophages | 1 | 2020 | 1547 | 0.020 |
Why?
| | RNA, Spliced Leader | 1 | 2011 | 12 | 0.020 |
Why?
| | Executive Function | 1 | 2017 | 451 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 900 | 0.020 |
Why?
| | Dinucleoside Phosphates | 1 | 2011 | 27 | 0.020 |
Why?
| | Software | 1 | 2017 | 665 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 57 | 0.020 |
Why?
| | Water | 1 | 2014 | 460 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4295 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 195 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 202 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 86 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 57 | 0.020 |
Why?
| | Schistosomiasis mansoni | 1 | 2009 | 23 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 469 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 118 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2009 | 145 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 976 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2009 | 103 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1226 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 307 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 445 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2013 | 3015 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7635 | 0.010 |
Why?
| | Molecular Motor Proteins | 1 | 2004 | 45 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5778 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1774 | 0.010 |
Why?
| | Nucleotides | 1 | 2004 | 125 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.010 |
Why?
| | Butanols | 1 | 2003 | 8 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 239 | 0.010 |
Why?
| | Threonine | 1 | 2003 | 47 | 0.010 |
Why?
| | Alcohols | 1 | 2003 | 27 | 0.010 |
Why?
| | Ions | 1 | 2003 | 70 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4030 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 664 | 0.010 |
Why?
| | Young Adult | 1 | 2017 | 13209 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2003 | 528 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 21513 | 0.010 |
Why?
| | Aged | 1 | 2017 | 23961 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 33479 | 0.010 |
Why?
|
|
Zhao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|